Company Announcements Under a mutual distribution agreement signed in July, Rigaku Reagents will promote and sell MiTeGen’s crystallization, crystal harvesting, data collection and other product lines worldwide, and MiTeGen will promote and sell Rigaku’s Wizard product lines of matrix screens and other products in the US. In August, Oxford Instruments appointed Hillsborough General Trading as […]
Company Announcements Advaita Bioinformatics entered into an exclusive distribution partnership with Riken Genesis in April for Japan for its iPathway Guide platform. Core Informatics announced in July the closing of a $17.5 million Series B funding, led by Oak HC/FT. In July, RURO partnered with Integrated Systems Engineering to provide its LIMS to biobanks, with […]
For the third straight year, Canada’s gross domestic expenditure on R&D (GERD) in 2015 is expected to decline, falling 0.7% to CAD 31.6 billion ($23.8 billion). This drop is predicted for spending in all performing sectors except higher education and the federal government, which are anticipated to experience 1.0% and 4.0% increases to CAD 13.0 […]
A survey by Farmaindustria found that Spain’s pharmaceutical industry spent €950 million ($1.06 billion) on R&D in 2014. This rise in investment followed three years of declines related to the economic crisis. Intramural research accounted for €568 million, or 59% of expenditures, while the remaining investment of €382 million was put toward research contracts with […]
A survey of 191 US universities, hospitals and research institutions, and one third-party technology investment firm showed gains in academic licensing and startup activity in 2014. These gains were despite a 5% drop in federal research funding to $37.9 billion. Respondents’ research expenditures overall fell 3.6% to $62.8 billion, but spending funded by industry rose […]
In 2016, the top 20 pharmaceutical companies’ sales of products gained through mergers and acquisitions are expected to match those of products developed within the companies. By net present value, only 36% of phase III drugs were internally developed, whereas 31%, 31% and 2% of them were obtained through acquisitions of companies, in-licensing and acquisitions […]
Based on the categorization of more than 35 million research papers into major disciplines by their journals of publication, and the proportion of references they cited from within or outside the same discipline, interdisciplinary research has been increasing since the mid-1980s. Three years following publication, the citation rates of articles decreased with the degree of […]
Despite a strong final trading session to end the month, US equity markets continued to falter in September due to anxiety over the economic slowdown in China and other emerging markets. Consequently, the Federal Reserve, which was equally pressured by uncertain global economic developments as well as by the strong valuation of the US dollar, […]
Mannheim, Germany 9/15/15; Cambridgeshire, UK 9/7/15—IVD firm ERBA Diagnostics Mannheim has acquired Lumora, a provider of diagnostic technology for clinical and industrial markets, for an undisclosed amount. “The acquisition of Lumora enhances our existing portfolio of instruments, test kits and reagents for clinical chemistry, microbiology, hematology, diabetes, immunology, urine chemistry, critical care and homeostasis testing,” […]
Tucson, AZ 9/18/15—Protein Technologies (PTI) has reached an agreement with Peptide Solutions (PSL) in its suit against the company alleging breach of contract, breach of fiduciary duty, misappropriation of trade secrets and proprietary information, and tortious interference (see IBO 1/31/15). PTI has withdrawn the case, and PSL has dropped its counterclaims.
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
